Wedbush Analysts Lower Earnings Estimates for RARE
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for shares of Ultragenyx Pharmaceutical in a research note issued on Wednesday, May 7th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of ($1.08) per share for the quarter, down from their […]
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for shares of Ultragenyx Pharmaceutical in a research note issued on Wednesday, May 7th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of ($1.08) per share for the quarter, down from their […]
